The Reticulocyte Count: An Educational Overview
Overview
Reticulocytes are immature red blood cells that still contain residual ribosomal RNA, distinguishing them from fully mature red cells. The reticulocyte count provides information about current bone-marrow erythropoietic activity and is commonly used alongside the CBC in the evaluation of anemia.
How reticulocytes are identified and measured
Reticulocytes can be identified using supravital stains (such as new methylene blue), which precipitate residual RNA into a visible reticular (network-like) pattern, allowing manual microscopic counting. Many laboratories now use automated hematology or flow-based analyzers that identify reticulocytes using fluorescent RNA-binding dyes, providing more precise and reproducible counts than manual methods.
Reporting the reticulocyte count
Reticulocyte results can be reported in several ways:
- Reticulocyte percentage: the proportion of red cells that are reticulocytes.
- Absolute reticulocyte count: the actual number of reticulocytes per volume of blood, generally considered more informative than percentage alone, particularly when the total red-cell count is abnormal.
- Corrected reticulocyte count / reticulocyte production index: calculations that adjust the reticulocyte percentage for the degree of anemia and, in some formulas, for the longer maturation time of reticulocytes released early from the marrow, intended to better reflect true marrow output.
- Immature reticulocyte fraction (IRF): a parameter available on some automated analyzers reflecting the proportion of reticulocytes that are relatively more immature, which can provide an earlier indicator of marrow response than the standard reticulocyte count in certain clinical situations, such as early marrow recovery after treatment.
Why correction matters
A raw reticulocyte percentage can be misleading in the presence of anemia, since the total red-cell count is reduced. A correction accounts for this by adjusting for the patient's hematocrit relative to a normal value, and, in more detailed formulas, for the fact that reticulocytes released prematurely into the circulation during a strong marrow response tend to remain reticulocytes for longer than usual, which can otherwise overestimate marrow output if not accounted for.
Clinical and laboratory uses
- Distinguishing whether anemia reflects an appropriate marrow response (elevated reticulocyte count, as with hemolysis or recent blood loss) or an inadequate one (low or inappropriately normal reticulocyte count, as with many production-related causes of anemia)
- Monitoring marrow recovery after chemotherapy, marrow transplantation, or treatment of a nutritional deficiency
- Supporting evaluation of suspected hemolytic conditions, generally alongside other hemolysis markers
Preanalytical and analytical considerations
- Reticulocyte counts are typically performed on anticoagulated whole blood and are relatively stable for a defined period under proper storage, though specific stability should follow the laboratory's validated procedure.
- Manual reticulocyte counting is subject to greater imprecision than automated flow-based methods, given the relatively small number of cells typically counted.
- Certain conditions, such as the presence of red-cell inclusions or nucleated red cells, can interfere with some counting methods and may require method-specific consideration.
Key points
- Reticulocytes are immature red cells containing residual RNA, identifiable by specific staining or fluorescent methods.
- Results can be reported as a percentage, absolute count, corrected count, or immature reticulocyte fraction.
- Correction for the degree of anemia improves the clinical usefulness of the reticulocyte percentage.
- The reticulocyte count helps distinguish an appropriate from an inadequate marrow response in anemia.
- It is also used to monitor marrow recovery after treatment.
References
- NCBI. MeSH: Reticulocytes.
- MedlinePlus. Reticulocyte Count.
- World Health Organization. Laboratory Quality Management System: Handbook.